定向软通道颅内血肿引流术联合自体血清治疗高血压脑出血的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of directional soft-channel intracranial hematoma drainage combined with autologous serum in the treatment of hypertensive cerebral hemorrhage.Methods From January 2018 to June 2019,70 patientswith hypertensive cerebral hemorrhage treated in our hospitalwere selected as the research subjects.They were divided into control group (n=35)and observation group (n=35)according to the random number table method.In the control group,directional soft-channel intracranial hematoma drainage combined with Urokinase was used,and in the observation group,directional soft-channel intracranial hematoma drainage combined with autologous serum was applied.The total clinical treatment efficiency,total incidence of complications,and changes in the Glasgow coma scale(GCS)and Scandinavian stroke scale(SSS)scores of patients in the two groupswere compared.Results The total effective rate of clinical treatment in the observation group was 97.14%,higher than 82.86%in the control group,and the difference was statistically significant(P＜0.05).The total incidence of complications in the observation group was 5.71%,lower than 22.86%in the control group,and the difference was statistically significant(P＜0.05).Before treatment,there were no significant difference in GCSor SSS scores between the two groups(P＞0.05).After treatment,the GCS scores in the two groupswere higher than those before treatment,the SSS scoreswere lower than those before treatment,in the observation group,the GCS score was higher than that of the control group,the SSS score was lower than that of the control group,and the differenceswere statistically significant(P＜0.05).Conclusion Patientswith hypertensive intracerebral hemorrhage treated with directional soft-channel intracranial hematoma drainage combined with autologous serum obtains remarkable effects,which can greatly improve the GCS and SSS scores of patients,and improve their coma and neurological injury with a high total effective rate and few complications.

Key words： Hypertensive cerebral hemorrhage Directional soft-channel intracranial hematoma drainage Autologous serum Efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QI bo

Cite this article:

QI bo. Effect of directional soft-channel intracranial hematoma drainage combined with autologous serum in the treatment of hypertensive cerebral hemorrhage[J]. 中国当代医药, 2020, 27(17): 73-76.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I17/73

[1]	宋香茹.微创颅内血肿穿刺引流术治疗高血压脑出血的护理及对患者ADL评分的影响[J].中国校医，2018，32（6）：472-473，475.
[2]	李振喆.高血压脑出血微创血肿引流25例临床效果观察实践探究[J].心理月刊，2019，14（11）：174.
[3]	韦益停，徐黔，陈芳芳.经额定向软通道颅内微创穿刺引流术联合干细胞移植治疗高血压脑出血的比较研究[J].中国卫生检验杂志，2015，25（10）：1558-1560.
[4]	朱灼坤，翁绮贞，罗成焕.脑出血应用微创颅内血肿抽吸引流术治疗的临床作用分析[J].现代诊断与治疗，2019，30（8）：1201-1202.
[5]	沈伟锋，王雪新.脑出血颅内血肿微创穿刺引流术首次血肿抽吸率与神经功能恢复相关性分析[J].实用医院临床杂志，2019，16（1）：105-108.
[6]	连立飞，许峰，梁奇明，等.颅内血肿微创抽吸引流术联合rt-PA治疗自发性脑出血的初步观察[J].神经损伤与功能重建，2018，13（3）：113-116.
[7]	中华医学会神经病学分会.中国脑血管病诊治指南与共识（2016版）[M].北京：人民卫生出版社，2016：193.
[8]	赵悦，任海军.不同时机微创颅内血肿穿刺引流术对高血压脑出血患者血清神经元特异性烯醇化酶、脑源性神经营养因子和同型半胱氨酸水平的影响[J].临床外科杂志，2018，26（9）：689-692.
[9]	王雷.高血压脑出血微侵袭血肿引流术与传统开颅血肿清除术的疗效对比研究[J].内蒙古医学杂志，2018，50（6）：696-698.
[10]	江砚明，肖伟鑫.醒脑静注射液联合软通道微创血肿引流术治疗高血压性脑出血的疗效观察[J].中国医院用药评价与分析，2018，18（11）：1495-1496，1499.
[11]	陈委，叶宇，欧阳锡华，等.微创引流术与开颅术治疗老年高血压脑出血病人疗效及对相关蛋白因子水平的影响[J].实用老年医学，2019，33（5）：480-483.
[12]	李仑.高血压脑出血颅内血肿穿刺置管引流术治疗及预后影响因素分析[J].智慧健康，2019，5（24）：51-52.
[13]	张晓飞，刘兴宇，崔建忠，等.血清脑源性神经营养因子水平对保守治疗的高血压脑出血患者抑郁情绪的影响[J].中国脑血管病杂志，2019，16（9）：466-470.
[14]	朱其锋，房博.软通道穿刺引流术治疗高血压性脑出血的临床效果[J].临床医学研究与实践，2019，4（31）：65-66.
[15]	毛华，陈涛.微创血肿引流术对老年高血压脑出血患者血清Tau蛋白、MIP-1α和GFAP的影响[J].现代中西医结合杂志，2018，27（10）：1112-1115.